Goyo Nagai - Concepedia

Author

Goyo Nagai

University of the Ryukyus ORCID

Also Known As

G. Nagai, Gabriel Massahiro Nagai, Goyo Nagai

Publications

342

Citations

H-Index

Concepts

All Affiliations

University of the Ryukyus Moscow Research and Clinical Center for Neuropsychiatry

About

Goyo Nagai is an author at University of the Ryukyus specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	140
2	Pharmacology	6	6	140
3	Social Sciences	1	1	39
4	Biochemistry	1	1	16
5	Metabolism	1	1	16

Goyo Nagai

Publications

309

Citations

H-Index

Page 1

	Year	Citations
Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia Takeshi Suzuki, Kazuo Mihara, A. Nakamura, Therapeutic Drug Monitoring	2014	57
Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia Takeshi Suzuki, Kazuo Mihara, A. Nakamura, Therapeutic Drug Monitoring Psychotropic MedicationPsychopharmacologyPharmacotherapyHigh FrequencyPre-clinical Pharmacology	2010	42
Pharmacokinetic and Pharmacodynamic Interactions Between Carbamazepine and Aripiprazole in Patients With Schizophrenia A. Nakamura, Kazuo Mihara, Goyo Nagai, Therapeutic Drug Monitoring Psychotropic MedicationPsychopharmacologyPharmacodynamic InteractionsPharmacotherapySocial Sciences	2009	39
Relationship Between Plasma Concentrations of Lamotrigine and Its Early Therapeutic Effect of Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder Shoko Kagawa, Kazuo Mihara, A. Nakamura, Therapeutic Drug Monitoring	2014	31
Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of<i>dopamine<scp>D</scp>2 receptor</i>and<i>cytochrome<scp>P</scp>450 2<scp>D</scp>6</i>in Japanese patients with schizophrenia Goyo Nagai, Kazuo Mihara, A. Nakamura, Psychiatry and Clinical Neurosciences	2012	28
Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy Takeshi Suzuki, Kazuo Mihara, Goyo Nagai, Therapeutic Drug Monitoring Plasma ConcentrationsPsychiatric DiseasePsychiatryMedicinePsychotropic Medication	2018	20
Formulations of Valproate Alter Valproate Metabolism: A Single Oral Dose Kinetic Study Goyo Nagai, Shingo Ono, Norio Yasui‐Furukori, Therapeutic Drug Monitoring Pharmaceutical SciencePharmacological StudyBiochemistryMedicineVpa Alter Metabolism	2009	16
Effects of Paroxetine on Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia Kenji Nemoto, Kazuo Mihara, A. Nakamura, Therapeutic Drug Monitoring	2012	16
Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder Shoko Kagawa, Kazuo Mihara, Takeshi Suzuki, Neuropsychobiology	2017	14
Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2 A. Nakamura, Kazuo Mihara, Goyo Nagai, Therapeutic Drug Monitoring	2016	13

Page 1